Amanote Research
Register
Sign In
Fas/Apo-1(cd95) Expression and Apoptosis in Patients With Myelodysplastic Syndromes
Leukemia
- United Kingdom
doi 10.1038/sj.leu.2400654
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Date
June 1, 1997
Authors
D Bouscary
J De Vos
M Guesnu
K Jondeau
F Viguier
J Melle
F Picard
F Dreyfus
M Fontenay-Roupie
Publisher
Springer Science and Business Media LLC
Related search
Bile Salts Differentially Sensitize Esophageal Squamous Cells to CD95 (Fas/Apo-1 Receptor) Mediated Apoptosis
Journal of Surgical Research
Surgery
Involvement of the CD95 (APO-1/Fas) Receptor and Ligand System in Helicobacter Pylori-Induced Gastric Epithelial Apoptosis.
Journal of Clinical Investigation
Medicine
The Central Executioner of Apoptosis: Multiple Connections Between Protease Activation and Mitochondria in Fas/Apo-1/Cd95- And Ceramide-Induced Apoptosis
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Involvement of Fas (CD95/APO-1) and Fas Ligand in Apoptosis Induced by Ganciclovir Treatment of Tumor Cells Transduced With Herpes Simplex Virus Thymidine Kinase
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Involvement of the CD95 (APO-1/Fas) Receptor/Ligand System in Multiple Sclerosis Brain
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Mutant P53 Gain of Function: Repression of CD95(Fas/APO-1) Gene Expression by Tumor-Associated P53 Mutants
Oncogene
Cancer Research
Genetics
Molecular Biology
Levels of Soluble Fas/Apo-1 in Patients With Behçet's Disease
Mediators of Inflammation
Immunology
Cell Biology
Expression Significance and Potential Mechanism of Hypoxia‐inducible Factor 1 Alpha in Patients With Myelodysplastic Syndromes
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Assessment of ATRX Expression in Patients With Myelodysplastic Syndromes Treated With Decitabine
Leukemia Research
Cancer Research
Oncology
Hematology
